Cargando…

Phosphogluconate dehydrogenase is a predictive biomarker for immunotherapy in hepatocellular carcinoma

BACKGROUND: Phosphogluconate dehydrogenase (PGD) is involved in the regulation of various tumors. However, its role in hepatocellular carcinoma (HCC) is poorly understood. This study tried to determine the prognostic efficacy of PGD and its value for immunotherapy in HCC. METHODS: The data from the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Tiantian, Qi, Jianni, Wu, Hao, Wang, Le, Zhu, Lihui, Qin, Chengyong, Zhang, Jiao, Zhu, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632284/ https://www.ncbi.nlm.nih.gov/pubmed/36338768 http://dx.doi.org/10.3389/fonc.2022.993503

Ejemplares similares

Seven immune‐related genes prognostic power and correlation with tumor‐infiltrating immune cells in hepatocellular carcinoma
por: Liu, Tiantian, et al.
Publicado: (2020)

Geobacillus stearothermophilus 6-phosphogluconate dehydrogenase complexed with 6-phosphogluconate
por: Cameron, Scott, et al.
Publicado: (2009)

6-Phosphogluconate dehydrogenase and its crystal structures
por: Hanau, Stefania, et al.
Publicado: (2022)

Four Autophagy-Related lncRNAs Predict the Prognosis of HCC through Coexpression and ceRNA Mechanism
por: Wu, Hao, et al.
Publicado: (2020)

Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer
por: Zheng, Wujian, et al.
Publicado: (2017)

Isoenzymes of hexokinase, 6-phosphogluconate dehydrogenase, phosphoglucomutase and lactate dehydrogenase in uterine cancer.
por: Marshall, M. J., et al.
Publicado: (1979)

Virtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase
por: Ruda, Gian Filippo, et al.
Publicado: (2010)

In Silico Analysis of Arabidopsis thaliana Peroxisomal 6-Phosphogluconate Dehydrogenase
por: Fernández-Fernández, Álvaro D., et al.
Publicado: (2016)

Crystal Structures of 6-Phosphogluconate Dehydrogenase from Corynebacterium glutamicum
por: Yu, Hyeonjeong, et al.
Publicado: (2023)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
por: He, Yuqing, et al.
Publicado: (2021)

Advanced development of biomarkers for immunotherapy in hepatocellular carcinoma
por: Peng, Xuenan, et al.
Publicado: (2023)

Origins of a cyanobacterial 6-phosphogluconate dehydrogenase in plastid-lacking eukaryotes
por: Maruyama, Shinichiro, et al.
Publicado: (2008)

Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1
por: He, Weiwei, et al.
Publicado: (2007)

A distinctively expressed long noncoding RNA, RP11‐466I1.1, may serve as a prognostic biomarker in hepatocellular carcinoma
por: Zhang, Junyong, et al.
Publicado: (2018)

Chloroplast-localized 6-phosphogluconate dehydrogenase is critical for maize endosperm starch accumulation
por: Spielbauer, Gertraud, et al.
Publicado: (2013)

Identification of Lignan Compounds as New 6-Phosphogluconate Dehydrogenase Inhibitors for Lung Cancer
por: Khan, Gul Bushra, et al.
Publicado: (2022)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
por: Guo, Zhanjun, et al.
Publicado: (2022)

Coenzyme Engineering of a Hyperthermophilic 6-Phosphogluconate Dehydrogenase from NADP(+) to NAD(+) with Its Application to Biobatteries
por: Chen, Hui, et al.
Publicado: (2016)

Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance
por: Liu, Ruilong, et al.
Publicado: (2019)

Non-AUG Translation Initiation Generates Peroxisomal Isoforms of 6-Phosphogluconate Dehydrogenase in Fungi
por: Kremp, Marco, et al.
Publicado: (2020)

The miR-545/374a Cluster Encoded in the Ftx lncRNA is Overexpressed in HBV-Related Hepatocellular Carcinoma and Promotes Tumorigenesis and Tumor Progression
por: Zhao, Qi, et al.
Publicado: (2014)

Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?
por: Rizzo, Alessandro, et al.
Publicado: (2021)

Application of Immunotherapy in Hepatocellular Carcinoma
por: Miao, Lele, et al.
Publicado: (2021)

Editorial: Immunotherapy in Hepatocellular Carcinoma
por: Li, Bin, et al.
Publicado: (2021)

A novel four-gene of iron metabolism-related and methylated for prognosis prediction of hepatocellular carcinoma
por: Shen, Huimin, et al.
Publicado: (2020)

ELOVLs Predict Distinct Prognosis Value and Immunotherapy Efficacy In Patients With Hepatocellular Carcinoma
por: Zhang, Yu, et al.
Publicado: (2022)

GLUCOSE-6-PHOSPHATE AND 6-PHOSPHOGLUCONATE DEHYDROGENASES FROM EGGS OF THE SEA URCHIN, ARBACIA PUNCTULATA
por: Krahl, M. E., et al.
Publicado: (1955)

Overexpression of a Cytosolic 6-Phosphogluconate Dehydrogenase Gene Enhances the Resistance of Rice to Nilaparvata lugens
por: Chen, Lin, et al.
Publicado: (2020)

lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma
por: Li, Xiao, et al.
Publicado: (2018)

HIF-1α regulates cellular metabolism, and Imatinib resistance by targeting phosphogluconate dehydrogenase in gastrointestinal stromal tumors
por: Xu, Kangjing, et al.
Publicado: (2020)

Implications of differential peroxyl radical-induced inactivation of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase for the pentose phosphate pathway
por: Reyes, Juan Sebastián, et al.
Publicado: (2022)

The functions and targets of miR‐212 as a potential biomarker of cancer diagnosis and therapy
por: Chen, Wenjun, et al.
Publicado: (2020)

Computational Characterizing Necroptosis Reveals Implications for Immune Infiltration and Immunotherapy of Hepatocellular Carcinoma
por: Zhu, Jun, et al.
Publicado: (2022)

High-Throughput Screening of Coenzyme Preference Change of Thermophilic 6-Phosphogluconate Dehydrogenase from NADP(+) to NAD(+)
por: Huang, Rui, et al.
Publicado: (2016)

Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to anti-malarial agent dihydroartemisinin
por: Elf, Shannon, et al.
Publicado: (2016)

Blockade of 6-phosphogluconate dehydrogenase generates CD8(+) effector T cells with enhanced anti-tumor function
por: Daneshmandi, Saeed, et al.
Publicado: (2021)

6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function
por: Daneshmandi, Saeed, et al.
Publicado: (2021)

A Simple Noninvasive Index Can Predict Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
por: Zhu, Lihui, et al.
Publicado: (2017)

Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response
por: Tian, Xi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r2hedt71dgu5q6lo6bm9rdh975